Universe Pharmaceuticals INC (NAS: UPC) Stock Analysis & Fundamentals

UPCUniverse Pharmaceuticals INC

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · universe-pharmacy.com

5.330USDMkt Cap: 3.54M $P/E: —1d ago

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the t…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap3.54M $

Enterprise Value-16.49M $

Revenue (TTM)17.74M $

Gross Profit6.30M $

Net Income (TTM)-3.67M $

Revenue/Share31.49 USD

Last Price5.330 USD

Fiscal Year EndSep 2025

MR QuarterMar 2026

Employees216

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA10.24

EV/Revenue-0.93

P/S0.20

P/B0.05

EPS (TTM)-1.39

EPS (Forward)—

52W Range

5.03071% of range5.450

52W High5.450 USD

52W Low5.030 USD

Profitability

Gross Margin35.28%

Oper. Margin-16.60%

EBITDA Margin-9.08%

Profit Margin-20.56%

ROE-6.54%

ROA-5.30%

Growth

Revenue Growth-1.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-5.05M $

CapEx (TTM)347.19K $

FCF Margin-120.81%

FCF Yield-605.71%

Net Debt-19.50M $

Net Debt/EBITDA12.11

Balance Sheet

Debt/Equity0.16

Current Ratio4.05

Quick Ratio3.25

Book Value/Sh99.64 USD

Cash/Share51.57 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:40

Split DateMar 24, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.631.76K

Float484.25K

Insiders1.44%

Institutions1.31%

Short Interest

Short Ratio0.0d

Short % Float1.02%

Short % Out.0.99%

Shares Short6.38K

Short (prev mo.)239.48K

Technical

SMA 504.732 (+12.6%)

SMA 2003.747 (+42.3%)

Beta1.53

S&P 52W Chg21.00%

Avg Vol (30d)17.38K

Avg Vol (10d)67.50K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—